Seventure bolsters investment committee
Venture house Seventure Partners has appointed Danilo Casadei Massari and Thomas Werner to the investment committee for its Health for Life Capital fund.
Seventure's Health for Life Capital fund reached a second close on €100m earlier this year. The life sciences fund has a specific focus on nutrition, resulting in its backing by dairy business Danone. Health for Life Capital explores opportunities linked to research involving the microbiome, which is the aggregate of microorganisms present in the human body.
Casadei Massari and Werner will work on identifying new investment opportunities, and more generally advise the VC on its strategy in the microbiome field.
Casadei Massari is an entrepreneur and has held a number of roles in the pharmaceutical field. He notably founded and led CM&D Pharma, a medical food company that was sold to Nestlé Health Science in 2011. Prior to that, Casadei Massari was vice president at Madaus Group, CEO of Madaus Italy and held several board appointments.
Werner specialises in advising businesses in the healthcare and nutrition sectors, holding executive and non-executive board positions for various companies. These include Basilea Pharmaceutica, Skyepharma and BSN Medical. Werner has also acted as managing director at GlaxoSmithKline (GSK) Germany and senior vice president at GSK. He was also managing director at Bristol-Myers Squibb Germany.
Latest News
Stonehage Fleming raises USD 130m for largest fund to date, eyes 2024 programme
Sponsor acquired the public software group in July 2017 via the same-year vintage Partners Group Global Value 2017
Stonehage Fleming raises USD 130m for largest fund to date, eyes 2024 programme
Czech Republic-headquartered family office is targeting DACH and CEE region deals
Stonehage Fleming raises USD 130m for largest fund to date, eyes 2024 programme
Ex-Rocket Internet leader Bettina Curtze joins Swiss VC firm as partner and CFO
Stonehage Fleming raises USD 130m for largest fund to date, eyes 2024 programme
Estonia-registered VC could bolster LP base with fresh capital from funds-of-funds or pension funds








